Advice on the prescription of adrenaline auto-injectors (AAIs) for severe allergic reactions

07 September 2018

Following a European review into adrenaline auto-injectors (AAIs), such as EpiPens, the Medicines and Healthcare products Regulatory Agency has issued national recommendations that healthcare professionals should prescribe two AAIs to adults and children with allergies who are at risk of having a severe allergic reaction (anaphylaxis). The guidance also recommends that people should carry their AAI devices on them at all times.

Barking and Dagenham, Havering and Redbridge (BHR) Clinical Commissioning Groups’ previous policy was to prescribe two AAIs for adults and children, and there has been no change to this.

Guidance for schools on emergency AAIs

Guidance from the Department of Health and Social Care, which was issued to schools last year, states that from 1 October 2017 schools in England are allowed to purchase AAI devices without a prescription, for emergency use on children who are at risk of anaphylaxis but whose own device is not available or not working. Therefore schools are responsible for purchasing their own emergency stocks of AAIs and no additional AAIs will be prescribed by BHR GPs for storage at school.

Please note that children are NOT expected to self-administer AAIs whilst at school. Schools should still have procedures in place to support children in administering AAIs and in managing the storage of AAIs on their premises.